"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value";"Value"
"CHEMBL382604";"";"None";"457.57";"1";"5.03";"13";"O=C(CCCN1CCC(C(O)(c2ccccc2)c2ccccc2)CC1)c1ccc2c(c1)OCO2";"IC50";"'='";"6700.0";"nM";"5.17";"";"";"UO_0000065";"11.31";"0.21";"0.14";"8.77";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"6.7"
"CHEMBL208528";"";"None";"455.64";"1";"6.25";"4";"CCCc1ccc(C(=O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"Ki";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"14.92";"0.27";"0.55";"16.76";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"160.0"
"CHEMBL589135";"";"None";"379.29";"0";"4.75";"32";"O=C(NCc1ccc(Cl)cc1Cl)N1CCC(Oc2ccccc2)CC1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1074710";"Inhibition of CYP2J2";"A";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153202";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"1.4"
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"Danazol";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"Ki";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3535115";"Mixed inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation in presence of NADPH";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"20.0"
"CHEMBL1483";"ALBENDAZOLE";"4.0";"265.34";"0";"3.24";"Albendazole";"CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1";"Activity";"'='";"65.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"65.5"
"CHEMBL1648";"ISRADIPINE";"4.0";"371.39";"0";"2.58";"Isradipine";"COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12";"Activity";"'='";"13.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"13.6"
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"Danazol";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3535114";"Inhibition of CYP2J2 in human liver microsomes using 7 probe cocktail containing phenacetin, paclitaxel, diclofenac, S-mephenytoin, dextromethorphan, astemizole and midazolam after 8 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"0.1"
"CHEMBL296419";"ASTEMIZOLE";"4.0";"458.58";"1";"5.35";"Astemizole";"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1";"CL";"'='";"3.05";"uL/min";"";"";"";"UO_0000271";"";"";"";"";"0";"CHEMBL3541100";"Drug metabolism assessed as human recombinant CYP2J2-mediated intrinsic clearance assessed per pmol protein after 30 mins";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"3.05"
"CHEMBL30008";"FLUNARIZINE";"4.0";"404.50";"1";"5.39";"Flunarizine";"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1";"Ki";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541092";"Non-competitive inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method and Dixon plot";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.1"
"CHEMBL3327064";"";"None";"357.38";"0";"3.47";"4";"CC(C)C(=O)N1CCC(NC(=O)Nc2ccc(C(F)(F)F)cc2)CC1";"Activity";"'='";"81.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3371006";"Inhibition of human CYP2J2 assessed as remaining activity at 10 uM";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351722";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"81.6"
"CHEMBL1085745";"";"None";"365.36";"0";"3.68";"3, Table1";"O=C(NCc1ccccc1OC(F)(F)F)N1CCC(c2ccncc2)C1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"13.69";"0.26";"1.32";"9.18";"0";"CHEMBL1119168";"Inhibition of CYP2J2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155546";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"10.0"
"CHEMBL27";"PROPRANOLOL";"4.0";"259.35";"0";"2.58";"Propranolol";"CC(C)NCC(O)COc1cccc2ccccc12";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL41";"FLUOXETINE";"4.0";"309.33";"0";"4.44";"Fluoxetine";"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL1592";"QUINAPRIL";"4.0";"438.52";"0";"2.57";"Quinapril";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O";"Activity";"'='";"51.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"51.4"
"CHEMBL900";"ORPHENADRINE";"4.0";"269.39";"0";"3.66";"ORPHENADRINE";"Cc1ccccc1C(OCCN(C)C)c1ccccc1";"Activity";"'='";"102.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"102.2"
"CHEMBL436774";"AR9281";"2.0";"319.45";"0";"2.27";"APAU";"CC(=O)N1CCC(NC(=O)NC23CC4CC(CC(C4)C2)C3)CC1";"Activity";"'='";"140.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3371006";"Inhibition of human CYP2J2 assessed as remaining activity at 10 uM";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351722";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"140.0"
"CHEMBL1592";"QUINAPRIL";"4.0";"438.52";"0";"2.57";"Quinapril";"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O";"Activity";"'='";"64.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"64.1"
"CHEMBL1370";"BUDESONIDE";"4.0";"430.54";"0";"2.72";"Budesonide";"CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1";"Activity";"'='";"50.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"50.8"
"CHEMBL296035";"BUFURALOL";"2.0";"261.37";"0";"3.42";"Bufuralol";"CCc1cccc2cc(C(O)CNC(C)(C)C)oc12";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL651";"METHADONE";"4.0";"309.45";"0";"4.29";"Methadone";"CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1";"Activity";"'='";"123.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"123.4"
"CHEMBL682";"AMODIAQUINE";"4.0";"355.87";"1";"5.18";"Amodiaquine";"CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O";"Activity";"'='";"22.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"22.5"
"CHEMBL1516";"OLMESARTAN";"3.0";"446.51";"0";"3.66";"Olmesartan";"CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL3526818";"";"None";"345.93";"0";"3.20";"[14C]-Fingolimod, FTY720";"CCCCCCCCc1ccc(CC[14C](N)(CO)CO)cc1.Cl";"Drug metabolism";"";"";"";"";"";"metabolite_not_detected";"";"";"";"";"";"0";"CHEMBL3533012";"Activity at human recombinant CYP2J2 expressed in baculovirus-infected BTI-TN-5B1-4 insect cell microsomes assessed as metabolite formation at 5 to 100 uM after 30 mins by HPLC-RA analysis";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"BTI-TN-5B1-4";"None";"TESTED_COMPOUND_NAME: [14C]-Fingolimod";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3525920";"1";"Scientific Literature";"Drug Metab Dispos";"2011";"CHEMBL3833782";"";"";"";""
"CHEMBL1484";"NICARDIPINE";"4.0";"479.53";"0";"3.68";"Nicardipine";"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1";"Activity";"'='";"8.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"8.9"
"CHEMBL2355051";"CLOMIPHENE";"4.0";"405.97";"1";"6.56";"Clomiphene";"CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1";"Activity";"'='";"108.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"108.8"
"CHEMBL41";"FLUOXETINE";"4.0";"309.33";"0";"4.44";"Fluoxetine";"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1";"Activity";"'='";"44.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"44.3"
"CHEMBL54";"HALOPERIDOL";"4.0";"375.87";"0";"4.43";"Haloperidol";"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1";"Activity";"'='";"15.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"15.6"
"CHEMBL4203313";"";"None";"538.59";"1";"4.94";"12";"COc1cc2c(c(OC)c1OC)-c1c(cc(O)c(OC)c1OC)C[C@H](C)[C@](C)(O)[C@H]2OC(=O)c1ccccc1";"Drug metabolism";"";"";"";"";"";"Metabolite_Notdetected";"";"";"";"";"";"0";"CHEMBL4185365";"Substrate activity at recombinant human CYP2J2 expressed in bactosomes assessed as CYP2J2-mediated benzoic acid (6R,7S)-2,6,10-trihydroxy-1,3,11,12-tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydro-dibenzo[a,c]cycloocten-5-yl ester formation at 5 to 50 uM after 30 mins in presence of NADPH by UFLC-DAD analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4184142";"1";"Scientific Literature";"J Med Chem";"2017";"None";"";"";"";""
"CHEMBL480";"LANSOPRAZOLE";"4.0";"369.37";"0";"3.52";"Lansoprazole";"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL589136";"";"None";"381.26";"0";"3.54";"33";"O=C(NCc1ccc(Cl)cc1Cl)N1CCC(Oc2ncccn2)CC1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1074710";"Inhibition of CYP2J2";"A";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153202";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"20.0"
"CHEMBL83";"TAMOXIFEN";"4.0";"371.52";"1";"6.00";"Tamoxifen";"CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1";"Activity";"'='";"9.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"9.1"
"CHEMBL3527324";"";"None";"625.50";"2";"5.73";"M2";"CC(C)(CO)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3537745";"Drug metabolism assessed as recombinant CYP2J2 (unknown origin)-mediated compound formation treated with AMG 853 at 10 uM after 30 mins by LC-MS/MS analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526017";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";""
"CHEMBL3527325";"";"None";"625.50";"2";"5.86";"M3";"CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3(O)CC3)cc2Cl)c1";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3537745";"Drug metabolism assessed as recombinant CYP2J2 (unknown origin)-mediated compound formation treated with AMG 853 at 10 uM after 30 mins by LC-MS/MS analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526017";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";""
"CHEMBL3527324";"";"None";"625.50";"2";"5.73";"M2";"CC(C)(CO)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1";"Km";"'='";"4530.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3538278";"Drug metabolism assessed as recombinant CYP2J2 (unknown origin)-mediated compound formation measured per nmol protein treated with AMG 853 after 15 mins by LC-MS/MS analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526017";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"4.53"
"CHEMBL3527325";"";"None";"625.50";"2";"5.86";"M3";"CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3(O)CC3)cc2Cl)c1";"Vmax";"'='";"0.299";"nmol/min";"";"";"";"";"";"";"";"";"0";"CHEMBL3538278";"Drug metabolism assessed as recombinant CYP2J2 (unknown origin)-mediated compound formation measured per nmol protein treated with AMG 853 after 15 mins by LC-MS/MS analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526017";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"0.299"
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"Clozapine";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"Drug metabolism";"'='";"0.03";"nmol/min";"";"";"";"";"";"";"";"";"0";"CHEMBL3536999";"Drug metabolism in supersomes expressing human recombinant CYP2J2 assessed as enzyme-mediated total GSH conjugate formation at 100 uM after 30 mins measured per nmol of P450 by HPLC analysis in presence of GSH and hGST P1-1";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3525934";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.03"
"CHEMBL3508698";"";"None";"671.83";"1";"3.29";"[14C]Aliskiren hemifumarate, [14C]-SPP100 hemifumarate";"COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC([14CH3])([14CH3])C(N)=O)C(C)C)C(C)C)ccc1OC.O=C(O)/C=C/C(=O)O";"Vmax";"'='";"604.4";"pmol.min.mg-1";"";"";"OUTCOME = Detected";"";"";"";"";"";"0";"CHEMBL3509256";"Enzyme kinetics constant (Vmax value) for CYP2J2 was determined in human liver microsome incubated with [14C]SPP100 hemifumarate";"A";"BAO_0000251";"microsome format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsome";"ASSAY_TEST: Vmax | DATASET: Metabolism | STUDY_ID: DMPK R0101129 | TESTED_COMPOUND_ID = 2468143.0 None | TESTED_COMPOUND_NAME: [14C]Aliskiren hemifumarate";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3508693";"28";"FDA approval pharmacokinetics/metabolism";"";"";"None";"";"";"";"604.4"
"CHEMBL1200633";"IVERMECTIN";"4.0";"1736.18";"None";"None";"Ivermectin";"CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"Activity";"'='";"26.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"26.2"
"CHEMBL207832";"";"None";"469.67";"1";"6.64";"6";"CCCCc1ccc(C(=O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"13.10";"0.24";"-0.49";"15.18";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"0.7"
"CHEMBL378460";"";"None";"513.68";"2";"5.79";"9";"CC(=O)OCCCc1ccc(C(=O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"10.91";"0.20";"-0.19";"8.38";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"2.5"
"CHEMBL207831";"";"None";"453.63";"1";"6.03";"5";"C=CCc1ccc(C(=O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"14.10";"0.26";"0.37";"15.78";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"0.4"
"CHEMBL207389";"";"None";"457.61";"0";"4.83";"7";"O=C(CCCN1CCC(C(O)(c2ccccc2)c2ccccc2)CC1)c1ccc(CCO)cc1";"IC50";"'='";"1300.0";"nM";"5.89";"";"";"UO_0000065";"12.86";"0.24";"1.06";"9.69";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"1.3"
"CHEMBL4748352";"LXE-408";"2.0";"443.44";"0";"4.16";"1, LXE408";"Cc1nc(C)c(C(=O)Nc2ccc(F)c(-c3nc4ncc(-c5ncccc5C)cn4n3)c2)o1";"Drug metabolism";"";"";"";"";"";"Metabolite_Detected";"";"";"";"";"";"0";"CHEMBL4668831";"Drug metabolism assessed as human CYP2j2-mediated N-(4-fluoro-3-(6-(3-methylpyri din-2-yl)-[1,2,4]triazolo[1,5- a]pyrimidin-2-yl)phenyl)-2-(hy droxymethyl)-4-methyloxazole-5 -carboxamide formation";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4665701";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";"";""
"CHEMBL6966";"VERAPAMIL";"4.0";"454.61";"1";"5.09";"Verapamil";"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC";"Activity";"'='";"1.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"1.3"
"CHEMBL204362";"";"None";"471.64";"1";"5.22";"8";"O=C(CCCN1CCC(C(O)(c2ccccc2)c2ccccc2)CC1)c1ccc(CCCO)cc1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"12.13";"0.22";"0.50";"9.41";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"1.9"
"CHEMBL589136";"";"None";"381.26";"0";"3.54";"1, Table1";"O=C(NCc1ccc(Cl)cc1Cl)N1CCC(Oc2ncccn2)CC1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"12.32";"0.26";"1.16";"6.98";"1";"CHEMBL1119168";"Inhibition of CYP2J2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155546";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"20.0"
"CHEMBL1083622";"";"None";"452.51";"0";"4.53";"6, Table1";"O=C(NCCC(c1ccc(F)cc1)c1ccc(F)cc1)N1CCC(Oc2cnccn2)CC1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1119168";"Inhibition of CYP2J2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155546";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";""
"CHEMBL1085743";"";"None";"422.48";"0";"4.48";"7, Table1";"O=C(NCCC(c1ccc(F)cc1)c1ccc(F)cc1)N1CCC(c2cnccn2)C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1119168";"Inhibition of CYP2J2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155546";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";""
"CHEMBL1085744";"";"None";"395.38";"0";"3.73";"5, Table1";"O=C(NCc1ccccc1OC(F)(F)F)N1CCC(Oc2ccncc2)CC1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"12.65";"0.24";"1.27";"7.85";"0";"CHEMBL1119168";"Inhibition of CYP2J2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155546";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"10.0"
"CHEMBL207982";"";"None";"441.62";"1";"5.86";"3";"CCc1ccc(C(=O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"14.09";"0.26";"0.36";"15.35";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"0.6"
"CHEMBL296419";"ASTEMIZOLE";"4.0";"458.58";"1";"5.35";"Astemizole";"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1";"Drug metabolism";"'='";"32.0";"pmol/min";"";"";"";"";"";"";"";"";"0";"CHEMBL3530848";"Drug metabolism in human liver microsomes assessed as CYP2J2-mediated astemizole O-demethylation measured per pmol protein at 0.3 uM after 5 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"32.0"
"CHEMBL560537";"";"None";"316.40";"0";"4.03";"1";"O=C(NCCC(c1ccccc1)c1ccccc1)c1cccnc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL1058985";"Inhibition of CYP2J2";"A";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153540";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";"";""
"CHEMBL207278";"";"None";"427.59";"1";"5.61";"2";"Cc1ccc(C(=O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"14.39";"0.26";"0.54";"15.18";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"0.7"
"CHEMBL17157";"TERFENADINE";"4.0";"471.69";"1";"6.45";"terfenadine";"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"8100.0";"nM";"5.09";"";"";"UO_0000065";"10.79";"0.20";"-1.36";"11.65";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"8.1"
"CHEMBL3527325";"";"None";"625.50";"2";"5.86";"M3";"CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3(O)CC3)cc2Cl)c1";"Km";"'='";"40700.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3538278";"Drug metabolism assessed as recombinant CYP2J2 (unknown origin)-mediated compound formation measured per nmol protein treated with AMG 853 after 15 mins by LC-MS/MS analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526017";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"40.7"
"CHEMBL205154";"TERFENADONE";"None";"469.67";"1";"6.60";"1";"CC(C)(C)c1ccc(C(=O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"13.10";"0.24";"-0.45";"15.18";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"0.7"
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"Clozapine";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"Drug metabolism";"'='";"0.7";"nmol/min";"";"";"";"";"";"";"";"";"0";"CHEMBL3541780";"Drug metabolism in supersomes expressing human recombinant CYP2J2 assessed as enzyme-mediated N-desmethylclozapine metabolite formation at 10 uM after 30 mins measured per nmol of P450 by HPLC analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3525934";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.7"
"CHEMBL2355051";"CLOMIPHENE";"4.0";"405.97";"1";"6.56";"Clomiphene";"CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1";"Activity";"'='";"44.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"44.2"
"CHEMBL1200633";"IVERMECTIN";"4.0";"1736.18";"None";"None";"Ivermectin";"CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O";"Activity";"'='";"20.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"20.9"
"CHEMBL3542265";"LY2452473";"2.0";"374.44";"0";"3.56";"LY2452473";"CC(C)OC(=O)N[C@H]1Cc2c(n(Cc3ccccn3)c3ccc(C#N)cc23)C1";"CL";"'='";"18.0";"uL/min";"";"";"";"UO_0000271";"";"";"";"";"0";"CHEMBL3531005";"Normalized intrinsic clearance assessed as human recombinant CYP2J2-mediated drug depletion per pmol protein by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3525964";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"18.0"
"CHEMBL383199";"";"None";"443.59";"1";"5.31";"10";"COc1ccc(C(=O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"7600.0";"nM";"5.12";"";"";"UO_0000065";"11.54";"0.21";"-0.19";"10.29";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"7.6"
"CHEMBL1017";"TELMISARTAN";"4.0";"514.63";"2";"7.26";"Telmisartan";"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"Ki";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3531440";"Mixed type inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.19"
"CHEMBL3183703";"";"None";"404.49";"0";"2.99";"MCC950";"CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1";"Drug metabolism";"'='";"1.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3864046";"Drug metabolism in Escherichia coli membranes expressing recombinant CYP2J2 (unknown origin) co-expressed with human NADPH-CPR/bacterial GroEL/GroES assessed as CYP2J2-mediated R-(+)- N-((1-hydroxy-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-4-(2-hydroxypropan-2-yl)furan-2-sulfonamide formation at 10 to 100 uM after 120 mins by LC-MS/MS analysis";"A";"BAO_0000249";"cell membrane format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3862040";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"";"";"1.1"
"CHEMBL3542336";"";"None";"494.58";"1";"5.63";"[14C]-SCH 530348";"CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=[14CH]/c1ccc(-c2cccc(F)c2)cn1";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3529567";"Activity of human recombinant CYP2J2 assessed as enzyme-mediated 2-hydroxyethyl (1R,3aR,4aR,6R,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-ylcarbamate formation at 25 uM after 120 mins by LC-MS/MS analysis in presence of NADPH";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"TESTED_COMPOUND_NAME: [14C]-SCH 530348";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526033";"1";"Scientific Literature";"Drug Metab Dispos";"2011";"None";"";"";"";""
"CHEMBL3542381";"";"None";"508.59";"1";"4.60";"M20";"C[C@H]1OC(=O)[C@@H]2C[C@@H]3C[C@H](NC(=O)OCCO)CC[C@H]3[C@H](/C=C/c3ccc(-c4cccc(F)c4)cn3)[C@H]12";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3531671";"Drug metabolism in human liver microsomes assessed as CYP2J2-mediated (3R,3aS,4S,4aR,7R,8aR,9aR)-7-amino-4-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-3-methyldecahydronaphtho[2,3-c]furan-1(3H)-one formation at 25 uM after 120 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"TESTED_COMPOUND_NAME: [14C]-SCH 530348";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526033";"1";"Scientific Literature";"Drug Metab Dispos";"2011";"None";"";"";"";""
"CHEMBL4463477";"";"None";"378.52";"0";"2.45";"16";"CNC(=O)C(=O)NCCCC/C=C\CCCCCCCCCc1nnn[nH]1";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4416900";"Inhibition of recombinant human CYP2J2 expressed in baculovirus infected insect cells co-expressing NADPH-CYP reductase and cytochrome b5 assessed as reduction in CYP2J2-mediated EPA epoxidation by measuring sum of EEQ and DiHETEs level at 1 to 50 uM using EPA as substrate preincubated for 5 mins followed by NADPH addition and measured after 15 mins by LCMS/MS analysis";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414645";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";""
"CHEMBL521";"IBUPROFEN";"4.0";"206.28";"0";"3.07";"Ibuprofen";"CC(C)Cc1ccc(C(C)C(=O)O)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL131";"PREDNISOLONE";"4.0";"360.45";"0";"1.56";"Prednisolone";"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL589136";"";"None";"381.26";"0";"3.54";"37";"O=C(NCc1ccc(Cl)cc1Cl)N1CCC(Oc2ncccn2)CC1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2072825";"Inhibition of CYP2J2";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069173";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"20.0"
"CHEMBL3527324";"";"None";"625.50";"2";"5.73";"M2";"CC(C)(CO)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1";"Ki";"'='";"240100.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3534693";"Inhibition of recombinant CYP2J2 (unknown origin) treated with AMG 853";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526017";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"240.1"
"CHEMBL445";"NORTRIPTYLINE";"4.0";"263.38";"0";"3.83";"Nortriptyline";"CNCCC=C1c2ccccc2CCc2ccccc21";"Activity";"'='";"70.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"70.1"
"CHEMBL651";"METHADONE";"4.0";"309.45";"0";"4.29";"Methadone";"CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1";"Activity";"'='";"43.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"43.0"
"CHEMBL2130955";"";"None";"290.24";"0";"4.48";"18";"O=c1cc(-c2ccc(C(F)(F)F)cc2)oc2ccccc12";"Inhibition";"'<'";"25.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL5115437";"Inhibition of recombinant human CYP2J2 expressed in baculovirus-infected insect cells at 50 uM incubated for 15 mins in presence of arachidonic acid and NADPH by jump-dilution assay relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113402";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"Dose = 50.0 microM | TIME = 0.25 hr";"";"";"25.0"
"CHEMBL3327078";"";"None";"387.40";"0";"3.74";"21";"CC[C@H](C)C(=O)N1CCC(NC(=O)Nc2ccc(OC(F)(F)F)cc2)CC1";"Activity";"'='";"60.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3371006";"Inhibition of human CYP2J2 assessed as remaining activity at 10 uM";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351722";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"60.6"
"CHEMBL206576";"";"None";"477.60";"1";"6.11";"12";"O=C(CCCN1CCC(C(O)(c2ccccc2)c2ccccc2)CC1)c1ccc(CC(F)F)cc1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"11.85";"0.22";"-0.45";"13.96";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"2.2"
"CHEMBL204998";"";"None";"492.46";"1";"6.06";"11";"O=C(CCCN1CCC(C(O)(c2ccccc2)c2ccccc2)CC1)c1ccc(Br)cc1";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"10.92";"0.23";"-0.68";"13.26";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"4.2"
"CHEMBL208528";"";"None";"455.64";"1";"6.25";"4";"CCCc1ccc(C(=O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"400.0";"nM";"6.40";"";"";"UO_0000065";"14.04";"0.26";"0.15";"15.78";"0";"CHEMBL869679";"Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"Sf9";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1147015";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2006";"CHEMBL3308860";"";"";"";"0.4"
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"amiodarone";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3529125";"Drug metabolism assessed as recombinant CYP2J2 (unknown origin)-mediated 4-hydroxyamiodarone formation at 1 uM after 20 mins by LC-MS/MS analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";""
"CHEMBL1085746";"";"None";"380.27";"0";"4.14";"2, Table1";"O=C(NCc1ccc(Cl)cc1Cl)N1CCC(Oc2ccncc2)CC1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"14.64";"0.30";"1.43";"10.23";"0";"CHEMBL1119168";"Inhibition of CYP2J2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155546";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"2.7"
"CHEMBL3508698";"";"None";"671.83";"1";"3.29";"[14C]Aliskiren hemifumarate, [14C]-SPP100 hemifumarate";"COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC([14CH3])([14CH3])C(N)=O)C(C)C)C(C)C)ccc1OC.O=C(O)/C=C/C(=O)O";"CL";"'='";"10.6";"ul.min.nmol-1";"";"";"OUTCOME = Detected";"";"";"";"";"";"0";"CHEMBL3509265";"Metabolic clearance (ul.min.nmol-1 CYP) of aliskiren hemifumarate for CYP2J2 was determined in human liver microsome incubated with [14C]SPP100 hemifumarate";"A";"BAO_0000251";"microsome format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsome";"ASSAY_TEST: CL | DATASET: Metabolism | STUDY_ID: DMPK R0101129 | TESTED_COMPOUND_ID = 2468143.0 None | TESTED_COMPOUND_NAME: [14C]Aliskiren hemifumarate";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3508693";"28";"FDA approval pharmacokinetics/metabolism";"";"";"None";"";"";"";"10.6"
"CHEMBL4218749";"";"None";"299.33";"0";"3.00";"8a";"COc1cc(/C=C/C(=O)c2ccncc2)cc(OC)c1OC";"IC50";"'>'";"20000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4181975";"Inhibition of human CYP2J2 expressed in yeast cells";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4177690";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";"";"20.0"
"CHEMBL3508698";"";"None";"671.83";"1";"3.29";"[14C]Aliskiren hemifumarate, [14C]-SPP100 hemifumarate";"COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC([14CH3])([14CH3])C(N)=O)C(C)C)C(C)C)ccc1OC.O=C(O)/C=C/C(=O)O";"Km";"'='";"67000.0";"nM";"";"";"OUTCOME = Detected";"UO_0000065";"";"";"";"";"0";"CHEMBL3509247";"Enzyme kinetics constant (Km value) for CYP2J2 was determined in human liver microsome incubated with [14C]SPP100 hemifumarate";"A";"BAO_0000251";"microsome format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsome";"ASSAY_TEST: Km | DATASET: Metabolism | STUDY_ID: DMPK R0101129 | TESTED_COMPOUND_ID = 2468143.0 None | TESTED_COMPOUND_NAME: [14C]Aliskiren hemifumarate";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3508693";"28";"FDA approval pharmacokinetics/metabolism";"";"";"None";"";"";"";"67.0"
"CHEMBL1404";"RANOLAZINE";"4.0";"427.55";"0";"2.31";"Ranolazine";"COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1";"Activity";"'='";"204.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"204.1"
"CHEMBL503";"LOVASTATIN";"4.0";"404.55";"0";"4.20";"Mevinolin";"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"Activity";"'='";"37.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"37.7"
"CHEMBL1423";"PIMOZIDE";"4.0";"461.56";"1";"5.86";"Pimozide";"O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1";"Activity";"'='";"6.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"6.6"
"CHEMBL1082684";"";"None";"396.37";"0";"3.13";"4, Table1";"O=C(NCc1ccccc1OC(F)(F)F)N1CCC(Oc2ncccn2)CC1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"14.38";"0.28";"2.57";"7.44";"0";"CHEMBL1119168";"Inhibition of CYP2J2";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155546";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"2.0"
"CHEMBL608263";"";"None";"423.30";"0";"4.44";"38";"O=C(O)c1ccc(OC2CCN(C(=O)NCc3ccc(Cl)cc3Cl)CC2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2072825";"Inhibition of CYP2J2";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069173";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"20.0"
"CHEMBL4473988";"";"None";"356.46";"0";"2.02";"4";"CNC(=O)C(=O)NCCCC/C=C\CCCCCCCOCC(=O)O";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4416900";"Inhibition of recombinant human CYP2J2 expressed in baculovirus infected insect cells co-expressing NADPH-CYP reductase and cytochrome b5 assessed as reduction in CYP2J2-mediated EPA epoxidation by measuring sum of EEQ and DiHETEs level at 1 to 50 uM using EPA as substrate preincubated for 5 mins followed by NADPH addition and measured after 15 mins by LCMS/MS analysis";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414645";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";""
"CHEMBL6966";"VERAPAMIL";"4.0";"454.61";"1";"5.09";"Verapamil";"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC";"Activity";"'='";"69.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"69.1"
"CHEMBL184";"ACYCLOVIR";"4.0";"225.21";"0";"-1.33";"Acyclovir";"Nc1nc2c(ncn2COCCO)c(=O)[nH]1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL172";"(S,R)-MEFLOQUINE";"None";"378.32";"0";"4.45";"Mefloquine";"O[C@@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@H]1CCCCN1";"Activity";"'='";"22.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"22.4"
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"Clozapine";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"Drug metabolism";"'='";"0.05";"nmol/min";"";"";"";"";"";"";"";"";"0";"CHEMBL3536206";"Drug metabolism in supersomes expressing human recombinant CYP2J2 assessed as enzyme-mediated cyanide adduct formation at 100 uM after 30 mins measured per nmol of P450 by HPLC analysis in presence of KCN";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3525934";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.05"
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"Danazol";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3535116";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation preincubated for 30 mins followed by substrate addition in presence of NADPH";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"0.012"
"CHEMBL3526948";"";"None";"661.32";"2";"5.91";"4-Hydroxyamiodarone";"CCN(CC)CCOc1c(I)cc(C(=O)c2c(CCCCO)oc3ccccc23)cc1I";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3529129";"Drug metabolism assessed as recombinant CYP2J2 (unknown origin)-mediated compound formation treated with amiodarone at 1 uM after 5 to 45 mins by LC-MS/MS analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";""
"CHEMBL3327065";"";"None";"355.36";"0";"3.23";"5";"O=C(Nc1ccc(C(F)(F)F)cc1)NC1CCN(C(=O)C2CC2)CC1";"Activity";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3371006";"Inhibition of human CYP2J2 assessed as remaining activity at 10 uM";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351722";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";""
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"amiodarone";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"Activity";"'='";"18.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"18.7"
"CHEMBL1484";"NICARDIPINE";"4.0";"479.53";"0";"3.68";"Nicardipine";"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1";"Activity";"'='";"5.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"5.8"
"CHEMBL560740";"";"None";"450.41";"1";"5.25";"30";"O=C(NCCC(c1ccc(F)cc1)c1ccc(F)cc1)c1ccc(OCC(F)(F)F)nc1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1058985";"Inhibition of CYP2J2";"A";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153540";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";"";"2.0"
"CHEMBL1428";"NIMODIPINE";"4.0";"418.45";"0";"2.97";"Nimodipine";"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1";"IC50";"'='";"3380.0";"nM";"5.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"3.38"
"CHEMBL1484";"NICARDIPINE";"4.0";"479.53";"0";"3.68";"Nicardipine";"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1";"IC50";"'='";"1690.0";"nM";"5.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"1.69"
"CHEMBL589135";"";"None";"379.29";"0";"4.75";"36";"O=C(NCc1ccc(Cl)cc1Cl)N1CCC(Oc2ccccc2)CC1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2072825";"Inhibition of CYP2J2";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069173";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"1.4"
"CHEMBL1082";"AMOXICILLIN";"4.0";"365.41";"0";"0.02";"Amoxicillin";"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL900";"ORPHENADRINE";"4.0";"269.39";"0";"3.66";"Orphenadrine";"Cc1ccccc1C(OCCN(C)C)c1ccccc1";"Activity";"'='";"1.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"1.2"
"CHEMBL5427131";"";"None";"592.94";"1";"4.60";"80; BAY2433334";"CC[C@@H](C(=O)Nc1ccc(C(N)=O)c(F)c1)n1cc(OC)c(-c2cc(Cl)ccc2-n2cc(C(F)(F)F)nn2)cc1=O";"IC50";"'>'";"41000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5367493";"Inhibition of CYP2J2 in human liver microsomes incubated for 15 mins in presence of NADPH by LC-MS/MS analysis";"A";"BAO_0000251";"microsome format";"Homo sapiens";"None";"Liver";"None";"Microsome";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5365459";"1";"Scientific Literature";"J Med Chem";"2023";"None";"TIME = 0.25 hr";"";"";"41.0"
"CHEMBL1423";"PIMOZIDE";"4.0";"461.56";"1";"5.86";"Pimozide";"O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3535114";"Inhibition of CYP2J2 in human liver microsomes using 7 probe cocktail containing phenacetin, paclitaxel, diclofenac, S-mephenytoin, dextromethorphan, astemizole and midazolam after 8 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"30.0"
"CHEMBL564085";"TROLEANDOMYCIN";"4.0";"813.98";"2";"3.62";"Troleandomycin";"CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL558";"MEXILETINE";"4.0";"179.26";"0";"2.03";"Mexiletine";"Cc1cccc(C)c1OCC(C)N";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL686";"MEFENAMIC ACID";"4.0";"241.29";"0";"3.75";"SID11112163";"Cc1cccc(Nc2ccccc2C(=O)O)c1C";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL23";"DILTIAZEM";"4.0";"414.53";"0";"3.37";"Diltiazem";"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL30";"CIMETIDINE";"4.0";"252.35";"0";"0.60";"Cimetidine";"CN/C(=N\CCSCc1nc[nH]c1C)NC#N";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL3542265";"LY2452473";"2.0";"374.44";"0";"3.56";"LY2452473";"CC(C)OC(=O)N[C@H]1Cc2c(n(Cc3ccccn3)c3ccc(C#N)cc23)C1";"CL";"'='";"1.79";"uL/min";"";"";"";"UO_0000271";"";"";"";"";"0";"CHEMBL3531000";"Intrinsic clearance assessed as human recombinant CYP2J2-mediated drug depletion per pmol protein by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3525964";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"1.79"
"CHEMBL480";"LANSOPRAZOLE";"4.0";"369.37";"0";"3.52";"Lansoprazole";"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1";"Activity";"'='";"71.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"71.1"
"CHEMBL480";"LANSOPRAZOLE";"4.0";"369.37";"0";"3.52";"Lansoprazole";"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1";"Activity";"'='";"0.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"0.7"
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"Danazol";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"'<'";"100.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3529113";"Inhibition of CYP2J2-mediated astemizole O-demethylation in human liver microsomes after 8 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"0.1"
"CHEMBL1109";"SULFAPHENAZOLE";"4.0";"314.37";"0";"2.26";"Sulfaphenazole";"Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL13";"METOPROLOL";"4.0";"267.37";"0";"1.61";"Metoprolol";"COCCc1ccc(OCC(O)CNC(C)C)cc1";"IC50";"'='";"4870.0";"nM";"5.31";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"4.87"
"CHEMBL556716";"";"None";"436.51";"0";"4.05";"24";"CS(=O)(=O)c1ccc(C(CCNC(=O)c2ccc(C#N)cc2)c2ccc(F)cc2)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1058985";"Inhibition of CYP2J2";"A";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153540";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";"";"3.0"
"CHEMBL193";"NIFEDIPINE";"4.0";"346.34";"0";"2.18";"Nifedipine";"COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]";"IC50";"'='";"3060.0";"nM";"5.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"3.06"
"CHEMBL389621";"HYDROCORTISONE";"4.0";"362.47";"0";"1.78";"Hydrocortisone";"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"Clozapine";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"IC50";"'='";"14100.0";"nM";"4.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"14.1"
"CHEMBL1017";"TELMISARTAN";"4.0";"514.63";"2";"7.26";"Telmisartan";"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"Ki";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541092";"Non-competitive inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method and Dixon plot";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.1"
"CHEMBL83";"TAMOXIFEN";"4.0";"371.52";"1";"6.00";"Tamoxifen";"CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1";"Activity";"'='";"11.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"11.5"
"CHEMBL493982";"VORAPAXAR";"4.0";"492.59";"1";"5.63";"SCH 530348, Vorapaxar";"CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1";"Inhibition";"'='";"87.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3534178";"Activity of human recombinant CYP2J2 assessed as enzyme-mediated ((4aR,6R)-9-{2-[(1R,4S)-5-((S)-3-Fluoro-phenyl)-pyridin-2-yl]-vinyl}-1-methyl-3-oxo-dodecahydro-naphtho[2,3-c]furan-6-yl)-carbamic acid(R)-2-hydroxy-ethyl ester formation at 10 uM after 120 mins by LC-MS/MS analysis in presence of astemizole";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"TESTED_COMPOUND_NAME: [14C]-SCH 530348";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526033";"1";"Scientific Literature";"Drug Metab Dispos";"2011";"None";"";"";"";"87.0"
"CHEMBL608";"PROBUCOL";"4.0";"516.86";"2";"9.91";"Probucol";"CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL3526948";"";"None";"661.32";"2";"5.91";"4-Hydroxyamiodarone";"CCN(CC)CCOc1c(I)cc(C(=O)c2c(CCCCO)oc3ccccc23)cc1I";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3529128";"Drug metabolism in human liver microsomes assessed as CYP2J2-mediated compound formation treated with amiodarone at 1 uM after 5 to 45 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";""
"CHEMBL1017";"TELMISARTAN";"4.0";"514.63";"2";"7.26";"telmisartan";"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"Ratio IC50";"'='";"1.0";"";"";"";"";"";"";"";"";"";"0";"CHEMBL3541099";"Ratio of IC50 for human recombinant CYP2J2 in absence of 1 mM NADPH to IC50 for human recombinant CYP2J2 in absence of 1 mM NADPH";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"1.0"
"CHEMBL54";"HALOPERIDOL";"4.0";"375.87";"0";"4.43";"Haloperidol";"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1";"Activity";"'='";"14.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"14.7"
"CHEMBL91";"MICONAZOLE";"4.0";"416.13";"1";"6.45";"Miconazole";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"IC50";"'='";"580.0";"nM";"6.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3529113";"Inhibition of CYP2J2-mediated astemizole O-demethylation in human liver microsomes after 8 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"0.58"
"CHEMBL17157";"TERFENADINE";"4.0";"471.69";"1";"6.45";"Terfenadine";"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"1830.0";"nM";"5.74";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3535114";"Inhibition of CYP2J2 in human liver microsomes using 7 probe cocktail containing phenacetin, paclitaxel, diclofenac, S-mephenytoin, dextromethorphan, astemizole and midazolam after 8 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"1.83"
"CHEMBL52440";"DEXTROMETHORPHAN";"4.0";"271.40";"0";"3.38";"Dextromethorphan";"COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL296419";"ASTEMIZOLE";"4.0";"458.58";"1";"5.35";"Astemizole";"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1";"Km";"'='";"90.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3531043";"Activity of human recombinant CYP2J2 assessed as compound O-demethylation";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.09"
"CHEMBL2130955";"";"None";"290.24";"0";"4.48";"18";"O=c1cc(-c2ccc(C(F)(F)F)cc2)oc2ccccc12";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5115436";"Inhibition of recombinant human CYP2J2 expressed in baculovirus-infected insect cells in presence of arachidonic acid and NADPH incubated for 15 mins by jump-dilution assay relative to control";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113402";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"INHIBITOR";"";"50.0"
"CHEMBL1423";"PIMOZIDE";"4.0";"461.56";"1";"5.86";"Pimozide";"O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3529113";"Inhibition of CYP2J2-mediated astemizole O-demethylation in human liver microsomes after 8 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"30.0"
"CHEMBL1648";"ISRADIPINE";"4.0";"371.39";"0";"2.58";"Isradipine";"COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12";"Activity";"'='";"23.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"23.7"
"CHEMBL1017";"TELMISARTAN";"4.0";"514.63";"2";"7.26";"Telmisartan";"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3531439";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation after 30 mins by LC-MS/MS method in presence of 1 mM NADPH";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.54"
"CHEMBL30008";"FLUNARIZINE";"4.0";"404.50";"1";"5.39";"Flunarizine";"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1";"IC50";"'='";"940.0";"nM";"6.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.94"
"CHEMBL1503";"OMEPRAZOLE";"4.0";"345.42";"0";"2.90";"Omeprazole";"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL9";"NORFLOXACIN";"4.0";"319.34";"0";"1.27";"Norfloxacin";"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21";"IC50";"'='";"2560.0";"nM";"5.59";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"2.56"
"CHEMBL12610";"BENZYDAMINE";"4.0";"309.41";"0";"3.42";"Benzydamine";"CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL3975957";"";"None";"463.90";"0";"2.39";"BDBM235143";"O=CN(C[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)C(=O)c1ccc(Cl)s1";"IC50";"'='";"6700.0";"nM";"5.17";"";"409800";"UO_0000065";"11.15";"0.23";"2.78";"5.36";"0";"CHEMBL3888578";"CYP Inhibition Assay: Incubation of phenacetin, diclofenac, dextromethorphan, mephenotoin, albendazole and testosterone with human liver microsomes in the presence of in each case eight different concentrations of a compound formula (B) (as potential inhibitor) is carried out on a incubator shaker at 37 C. Standard incubation mixtures comprise NADPH and substrates in 100 mM phosphate buffer (pH 7.4) in a total volume of 200 μl. Test compound are dissolved in acetonitrile. Incubated with pooled human liver microsomes at 37° C. for a defined time. The reactions are stopped by adding 100 μl of acetonitrile in which a suitable internal standard is always present. Precipitated proteins are removed by centrifugation, and the supernatants analyzed by LC-MS/MS.";"B";"BAO_0000221";"tissue-based format";"None";"CHEMBL3559723";"Liver";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886766";"37";"BindingDB Patent Bioactivity Data";"";"2016";"None";"";"";"";"6700.0"
"CHEMBL3542265";"LY2452473";"2.0";"374.44";"0";"3.56";"LY2452473";"CC(C)OC(=O)N[C@H]1Cc2c(n(Cc3ccccn3)c3ccc(C#N)cc23)C1";"Fm";"'='";"15.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3531010";"Fraction metabolized assessed as human recombinant CYP2J2-mediated drug depletion by LC-MS/MS method relative to total normalized intrinsic clearance";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3525964";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"15.0"
"CHEMBL384467";"DEXAMETHASONE";"4.0";"392.47";"0";"1.90";"Dexamethasone";"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL80";"NALOXONE";"4.0";"327.38";"0";"1.30";"Naloxone";"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL493982";"VORAPAXAR";"4.0";"492.59";"1";"5.63";"SCH 530348, Vorapaxar";"CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1";"Drug metabolism";"";"";"";"";"";"metabolite_not_detected";"";"";"";"";"";"0";"CHEMBL3536736";"Drug metabolism assessed as human recombinant CYP2J2-mediated 2-hydroxyethyl (1R,3aR,4aR,6R,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-ylcarbamate formation at 25 uM after 120 mins by LC-MS/MS analysis in presence of astemizole";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"TESTED_COMPOUND_NAME: [14C]-SCH 530348";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526033";"1";"Scientific Literature";"Drug Metab Dispos";"2011";"None";"";"";"";""
"CHEMBL139";"DICLOFENAC";"4.0";"296.15";"0";"4.36";"Diclofenac";"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL1503";"OMEPRAZOLE";"4.0";"345.42";"0";"2.90";"Omeprazole";"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1";"Activity";"'='";"70.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"70.5"
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"CLZ";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"Activity";"'='";"51.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"51.3"
"CHEMBL445";"NORTRIPTYLINE";"4.0";"263.38";"0";"3.83";"Nortriptyline";"CNCCC=C1c2ccccc2CCc2ccccc21";"Activity";"'='";"45.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"45.3"
"CHEMBL50";"QUERCETIN";"3.0";"302.24";"0";"1.99";"Quercetin";"O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12";"Activity";"'='";"44.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"44.7"
"CHEMBL1708";"PAROXETINE HYDROCHLORIDE";"4.0";"365.83";"0";"3.33";"Paroxetine";"Cl.Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1";"Activity";"'='";"39.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"39.0"
"CHEMBL157101";"KETOCONAZOLE";"4.0";"531.44";"1";"4.21";"Ketoconazole";"CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"Activity";"'='";"5.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"5.4"
"CHEMBL809";"SERTRALINE";"4.0";"306.24";"1";"5.18";"Sertraline";"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21";"IC50";"'='";"18500.0";"nM";"4.73";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"18.5"
"CHEMBL3527324";"";"None";"625.50";"2";"5.73";"M2";"CC(C)(CO)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1";"Vmax";"'='";"0.584";"nmol/min";"";"";"";"";"";"";"";"";"0";"CHEMBL3538278";"Drug metabolism assessed as recombinant CYP2J2 (unknown origin)-mediated compound formation measured per nmol protein treated with AMG 853 after 15 mins by LC-MS/MS analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526017";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"0.584"
"CHEMBL3327077";"";"None";"373.38";"0";"3.35";"19";"CC(C)C(=O)N1CCC(NC(=O)Nc2ccc(OC(F)(F)F)cc2)CC1";"Activity";"'='";"73.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3371006";"Inhibition of human CYP2J2 assessed as remaining activity at 10 uM";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351722";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"73.4"
"CHEMBL608263";"";"None";"423.30";"0";"4.44";"47";"O=C(O)c1ccc(OC2CCN(C(=O)NCc3ccc(Cl)cc3Cl)CC2)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1074710";"Inhibition of CYP2J2";"A";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1153202";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";"";"20.0"
"CHEMBL41";"FLUOXETINE";"4.0";"309.33";"0";"4.44";"Fluoxetine";"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1";"Activity";"'='";"87.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"87.0"
"CHEMBL296419";"ASTEMIZOLE";"4.0";"458.58";"1";"5.35";"Astemizole";"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1";"Activity";"'='";"8.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"8.3"
"CHEMBL54";"HALOPERIDOL";"4.0";"375.87";"0";"4.43";"Haloperidol";"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1";"IC50";"'='";"4690.0";"nM";"5.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"4.69"
"CHEMBL1451";"TRIAMCINOLONE";"4.0";"394.44";"0";"0.62";"Triamcinolone";"C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F";"IC50";"'='";"9470.0";"nM";"5.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"9.47"
"CHEMBL435";"HYDROCHLOROTHIAZIDE";"4.0";"297.75";"0";"-0.35";"Hydrochlorothiazide";"NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL45816";"MIBEFRADIL";"4.0";"495.64";"1";"5.27";"Mibefradil";"COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C";"IC50";"'='";"2140.0";"nM";"5.67";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"2.14"
"CHEMBL108";"CARBAMAZEPINE";"4.0";"236.27";"0";"3.39";"Carbamazepine";"NC(=O)N1c2ccccc2C=Cc2ccccc21";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL22";"TRIMETHOPRIM";"4.0";"290.32";"0";"1.26";"Trimethoprim";"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL1258904";"";"None";"359.35";"0";"3.11";"18, TPPU";"CCC(=O)N1CCC(NC(=O)Nc2ccc(OC(F)(F)F)cc2)CC1";"Activity";"'='";"91.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3371006";"Inhibition of human CYP2J2 assessed as remaining activity at 10 uM";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351722";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"91.9"
"CHEMBL503";"LOVASTATIN";"4.0";"404.55";"0";"4.20";"Mevinolin";"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"Activity";"'='";"13.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"13.6"
"CHEMBL1064";"SIMVASTATIN";"4.0";"418.57";"0";"4.59";"Simvastatin";"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"Activity";"'='";"5.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"5.0"
"CHEMBL493982";"VORAPAXAR";"4.0";"492.59";"1";"5.63";"SCH 530348, Vorapaxar";"CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1";"Drug metabolism";"";"";"";"";"";"metabolite_not_detected";"";"";"";"";"";"0";"CHEMBL3535001";"Drug metabolism assessed as human recombinant CYP2J2-mediated 2-hydroxyethyl (1R,3aR,4aR,6R,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-ylcarbamate formation at 25 uM after 120 mins by LC-MS/MS analysis in presence of ketoconazole";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"TESTED_COMPOUND_NAME: [14C]-SCH 530348";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526033";"1";"Scientific Literature";"Drug Metab Dispos";"2011";"None";"";"";"";""
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"amiodarone";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3529117";"Drug metabolism in human liver microsomes assessed as CYP2J2-mediated 4-hydroxyamiodarone formation at 1 uM after 5 to 45 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";""
"CHEMBL71";"CHLORPROMAZINE";"4.0";"318.87";"0";"4.89";"CHLORPROMAZINE";"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21";"IC50";"'='";"24400.0";"nM";"4.61";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"24.4"
"CHEMBL6966";"VERAPAMIL";"4.0";"454.61";"1";"5.09";"27";"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC";"IC50";"'='";"22000.0";"nM";"4.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"22.0"
"CHEMBL833";"TICLOPIDINE";"4.0";"263.79";"0";"3.96";"Ticlopidine";"Clc1ccccc1CN1CCc2sccc2C1";"IC50";"'='";"21800.0";"nM";"4.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"21.8"
"CHEMBL1802692";"";"None";"354.49";"0";"3.17";"2b";"CNC(=O)C(=O)NCCCC/C=C\CCCCCCCCCC(=O)O";"Inhibition";"";"";"%";"";"";"Not Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4416900";"Inhibition of recombinant human CYP2J2 expressed in baculovirus infected insect cells co-expressing NADPH-CYP reductase and cytochrome b5 assessed as reduction in CYP2J2-mediated EPA epoxidation by measuring sum of EEQ and DiHETEs level at 1 to 50 uM using EPA as substrate preincubated for 5 mins followed by NADPH addition and measured after 15 mins by LCMS/MS analysis";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414645";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";""
"CHEMBL498785";"";"None";"420.53";"0";"4.84";"M19";"C[C@H]1OC(=O)[C@@H]2C[C@@H]3C[C@H](N)CC[C@H]3[C@H](/C=C/c3ccc(-c4cccc(F)c4)cn3)[C@H]12";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3531672";"Drug level in human liver microsomes assessed as CYP2J2-mediated drug metabolism at 25 uM after 120 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"TESTED_COMPOUND_NAME: [14C]-SCH 530348";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526033";"1";"Scientific Literature";"Drug Metab Dispos";"2011";"None";"";"";"";""
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"Danazol";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"'='";"77.0";"nM";"7.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3529116";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation in presence of NADPH";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"0.077"
"CHEMBL682";"AMODIAQUINE";"4.0";"355.87";"1";"5.18";"Amodiaquine";"CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O";"Activity";"'='";"7.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"7.7"
"CHEMBL161";"CEFTRIAXONE";"4.0";"554.59";"2";"-1.20";"Ceftriaxone";"CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(O)nn3C)CS[C@H]12)c1csc(N)n1";"IC50";"'='";"27400.0";"nM";"4.56";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"27.4"
"CHEMBL3327067";"";"None";"371.40";"0";"3.86";"7";"CC[C@H](C)C(=O)N1CCC(NC(=O)Nc2ccc(C(F)(F)F)cc2)CC1";"Activity";"'='";"82.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3371006";"Inhibition of human CYP2J2 assessed as remaining activity at 10 uM";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3351722";"1";"Scientific Literature";"J Med Chem";"2014";"None";"";"";"";"82.6"
"CHEMBL91";"MICONAZOLE";"4.0";"416.13";"1";"6.45";"Miconazole";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"IC50";"'='";"640.0";"nM";"6.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3535114";"Inhibition of CYP2J2 in human liver microsomes using 7 probe cocktail containing phenacetin, paclitaxel, diclofenac, S-mephenytoin, dextromethorphan, astemizole and midazolam after 8 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"0.64"
"CHEMBL218394";"BOCEPREVIR";"4.0";"519.69";"1";"1.71";"[14C]boceprevir";"CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C";"Compound recovery";"";"";"";"";"";"metabolite_not_detected";"";"";"";"";"";"0";"CHEMBL3541894";"Drug metabolism assessed as human CYP2J2-mediated compound formation from 5 to 20 uM [14C]boceprevir after 120 mins by LC-MS/FSA method relative to total [14C]boceprevir";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"TESTED_COMPOUND_NAME: [14C]boceprevir";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526141";"1";"Scientific Literature";"Drug Metab Dispos";"2011";"None";"";"";"";""
"CHEMBL682";"AMODIAQUINE";"4.0";"355.87";"1";"5.18";"Amodiaquine";"CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O";"IC50";"'='";"990.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.99"
"CHEMBL479";"THIORIDAZINE";"4.0";"370.59";"1";"5.89";"Thioridazine";"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2";"Activity";"'='";"51.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"51.7"
"CHEMBL1951575";"VIDUPIPRANT";"2.0";"609.50";"2";"6.76";"AMG 853";"CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3538082";"Drug metabolism assessed as recombinant CYP2J2 (unknown origin)-mediated 2-(4-(4-(tert-butylcarbamoyl)-2-(2-chloro-4-(1-hydroxycyclopropyl)phenylsulfonamido)phenoxy)-5-chloro-2-fluorophenyl)acetic acid formation at 10 uM after 30 mins by LC-MS/MS analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526017";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";""
"CHEMBL154";"NAPROXEN";"4.0";"230.26";"0";"3.04";"Naproxen";"COc1ccc2cc([C@H](C)C(=O)O)ccc2c1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL532";"ERYTHROMYCIN";"4.0";"733.94";"2";"1.79";"Erythromycin";"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL30008";"FLUNARIZINE";"4.0";"404.50";"1";"5.39";"Flunarizine";"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1";"Ki";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3529761";"Non-competitive inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.13"
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"CLZ";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"Drug metabolism";"'='";"1.4";"nmol/min";"";"";"";"";"";"";"";"";"0";"CHEMBL3541853";"Drug metabolism in supersomes expressing human recombinant CYP2J2 assessed as enzyme-mediated N-desmethylclozapine metabolite formation at 100 uM after 30 mins measured per nmol of P450 by HPLC analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3525934";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"1.4"
"CHEMBL1404";"RANOLAZINE";"4.0";"427.55";"0";"2.31";"Ranolazine";"COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1";"Activity";"'='";"45.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"45.1"
"CHEMBL91";"MICONAZOLE";"4.0";"416.13";"1";"6.45";"Miconazole";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"Activity";"'='";"10.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"10.1"
"CHEMBL104";"CLOTRIMAZOLE";"4.0";"344.85";"1";"5.38";"Clotrimazole";"Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1";"Activity";"'='";"5.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"5.6"
"CHEMBL998";"LORATADINE";"4.0";"382.89";"0";"4.89";"Loratadine";"CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1";"Activity";"'='";"4.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"4.0"
"CHEMBL91";"MICONAZOLE";"4.0";"416.13";"1";"6.45";"Miconazole";"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1";"Activity";"'='";"3.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"3.4"
"CHEMBL104";"CLOTRIMAZOLE";"4.0";"344.85";"1";"5.38";"Clotrimazole";"Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1";"Activity";"'='";"14.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"14.1"
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"Danazol";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"Activity";"'='";"1.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"1.6"
"CHEMBL814";"FLUVOXAMINE";"4.0";"318.34";"0";"3.20";"Fluvoxamine";"COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1";"Activity";"'='";"48.7";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"48.7"
"CHEMBL1483";"ALBENDAZOLE";"4.0";"265.34";"0";"3.24";"Albendazole";"CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1";"Activity";"'='";"29.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"29.3"
"CHEMBL479";"THIORIDAZINE";"4.0";"370.59";"1";"5.89";"Thioridazine";"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2";"Activity";"'='";"12.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"12.9"
"CHEMBL421";"SULFASALAZINE";"4.0";"398.40";"0";"3.70";"SID26747277";"O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL652";"FLECAINIDE";"4.0";"414.35";"0";"3.44";"Flecainide";"O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL657";"DIPHENHYDRAMINE";"4.0";"255.36";"0";"3.35";"Diphenhydramine";"CN(C)CCOC(c1ccccc1)c1ccccc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL112";"ACETAMINOPHEN";"4.0";"151.16";"0";"1.35";"Acetaminophen";"CC(=O)Nc1ccc(O)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"Amiodarone";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3530847";"Drug metabolism in human liver microsomes assessed as CYP2J2-mediated 3-hydroxyamiodarone formation at 1 uM after 5 to 45 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";""
"CHEMBL1371";"CHLORZOXAZONE";"4.0";"169.57";"0";"1.77";"Chlorzoxazone";"O=c1[nH]c2cc(Cl)ccc2o1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL219916";"DOMPERIDONE";"4.0";"425.92";"0";"3.35";"Domperidone";"O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1";"Activity";"'='";"50.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"50.5"
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"Danazol";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"Activity";"'='";"8.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"8.0"
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"amiodarone";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"Drug metabolism";"'='";"3.1";"pmol/min";"";"";"";"";"";"";"";"";"0";"CHEMBL3530849";"Drug metabolism in human liver microsomes assessed as CYP2J2-mediated 4-hydroxyamiodarone formation measured per pmol protein at 5 uM after 20 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"3.1"
"CHEMBL1017";"TELMISARTAN";"4.0";"514.63";"2";"7.26";"SID144205005";"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.42"
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"CLZ";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"Drug metabolism";"'='";"0.05";"nmol/min";"";"";"";"";"";"";"";"";"0";"CHEMBL3539712";"Drug metabolism in supersomes expressing human recombinant CYP2J2 assessed as enzyme-mediated clozapine-N-oxide metabolite formation at 10 uM after 30 mins measured per nmol of P450 by HPLC analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3525934";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.05"
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"SID124879690";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"Drug metabolism";"'='";"0.009";"nmol/min";"";"";"";"";"";"";"";"";"0";"CHEMBL3540041";"Drug metabolism in supersomes expressing human recombinant CYP2J2 assessed as enzyme-mediated total GSH conjugate formation at 10 uM after 30 mins measured per nmol of P450 by HPLC analysis in presence of GSH and hGST P1-1";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3525934";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.009"
"CHEMBL1503";"OMEPRAZOLE";"4.0";"345.42";"0";"2.90";"Omeprazole";"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1";"Activity";"'='";"46.1";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"46.1"
"CHEMBL1708";"PAROXETINE HYDROCHLORIDE";"4.0";"365.83";"0";"3.33";"Paroxetine";"Cl.Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1";"Activity";"'='";"31.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"31.6"
"CHEMBL50";"QUERCETIN";"3.0";"302.24";"0";"1.99";"Quercetin";"O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12";"Activity";"'='";"29.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"29.8"
"CHEMBL669";"CYCLOBENZAPRINE";"4.0";"275.40";"0";"4.55";"Cyclobenzaprine";"CN(C)CCC=C1c2ccccc2C=Cc2ccccc21";"Activity";"'='";"65.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"65.9"
"CHEMBL814";"FLUVOXAMINE";"4.0";"318.34";"0";"3.20";"Fluvoxamine";"COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1";"Activity";"'='";"54.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"54.4"
"CHEMBL669";"CYCLOBENZAPRINE";"4.0";"275.40";"0";"4.55";"Cyclobenzaprine";"CN(C)CCC=C1c2ccccc2C=Cc2ccccc21";"Activity";"'='";"48.9";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"48.9"
"CHEMBL219916";"DOMPERIDONE";"4.0";"425.92";"0";"3.35";"Domperidone";"O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1";"Activity";"'='";"43.5";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"43.5"
"CHEMBL914";"FEXOFENADINE";"4.0";"501.67";"2";"5.51";"Fexofenadine";"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL567";"PERPHENAZINE";"4.0";"403.98";"0";"3.94";"Perphenazine";"OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1";"IC50";"'='";"10600.0";"nM";"4.97";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"10.6"
"CHEMBL1951575";"VIDUPIPRANT";"2.0";"609.50";"2";"6.76";"AMG 853";"CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3CC3)cc2Cl)c1";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3537740";"Drug metabolism assessed as recombinant CYP2J2 (unknown origin)-mediated 2-(5-chloro-4-(2-(2-chloro-4-cyclopropylphenylsulfonamido)-4-(1-hydroxy-2-methylpropan-2-ylcarbamoyl)phenoxy)-2-fluorophenyl)acetic acid formation at 10 uM after 30 mins by LC-MS/MS analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526017";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";""
"CHEMBL302795";"TENOXICAM";"4.0";"337.38";"0";"1.64";"Tenoxicam";"CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"SID124879690";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"Drug metabolism";"'='";"0.1";"nmol/min";"";"";"";"";"";"";"";"";"0";"CHEMBL3539723";"Drug metabolism in supersomes expressing human recombinant CYP2J2 assessed as enzyme-mediated clozapine-N-oxide metabolite formation at 100 uM after 30 mins measured per nmol of P450 by HPLC analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3525934";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.1"
"CHEMBL1790041";"RANITIDINE";"4.0";"314.41";"0";"1.46";"Ranitidine";"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL527";"PIROXICAM";"4.0";"331.35";"0";"1.58";"Piroxicam";"CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL72";"DESIPRAMINE";"4.0";"266.39";"0";"3.53";"Desipramine";"CNCCCN1c2ccccc2CCc2ccccc21";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL1017";"TELMISARTAN";"4.0";"514.63";"2";"7.26";"Telmisartan";"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1";"IC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3531438";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation reduction in astemizole O-demethylation after 30 mins by LC-MS/MS method in absence of 1 mM NADPH";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.54"
"CHEMBL3526949";"";"None";"661.32";"2";"5.91";"3-Hyroxyamiodarone";"CCN(CC)CCOc1c(I)cc(C(=O)c2c(CCC(C)O)oc3ccccc23)cc1I";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3529128";"Drug metabolism in human liver microsomes assessed as CYP2J2-mediated compound formation treated with amiodarone at 1 uM after 5 to 45 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";""
"CHEMBL571";"KETOPROFEN";"4.0";"254.29";"0";"3.11";"5; Ket";"CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL11";"IMIPRAMINE";"4.0";"280.42";"0";"3.88";"Imipramine";"CN(C)CCCN1c2ccccc2CCc2ccccc21";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL1064";"SIMVASTATIN";"4.0";"418.57";"0";"4.59";"Simvastatin";"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21";"Activity";"'='";"14.3";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"14.3"
"CHEMBL172";"(S,R)-MEFLOQUINE";"None";"378.32";"0";"4.45";"Mefloquine";"O[C@@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@H]1CCCCN1";"Activity";"'='";"44.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"44.6"
"CHEMBL157101";"KETOCONAZOLE";"4.0";"531.44";"1";"4.21";"Ketoconazole";"CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1";"Activity";"'='";"5.8";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"5.8"
"CHEMBL1729";"CISAPRIDE";"4.0";"465.95";"0";"3.36";"Cisapride";"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC";"Activity";"'='";"3.2";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"3.2"
"CHEMBL1479";"DANAZOL";"4.0";"337.46";"0";"4.22";"Danazol";"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3529115";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation in presence of NADPH";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"0.019"
"CHEMBL30008";"FLUNARIZINE";"4.0";"404.50";"1";"5.39";"Flunarizine";"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1";"Ratio IC50";"'='";"1.25";"";"";"";"";"";"";"";"";"";"0";"CHEMBL3541099";"Ratio of IC50 for human recombinant CYP2J2 in absence of 1 mM NADPH to IC50 for human recombinant CYP2J2 in absence of 1 mM NADPH";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"1.25"
"CHEMBL296419";"ASTEMIZOLE";"4.0";"458.58";"1";"5.35";"Astemizole";"COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1";"Vmax";"'='";"339.0";"pmol/min";"";"";"";"";"";"";"";"";"0";"CHEMBL3531436";"Activity of human recombinant CYP2J2 assessed as compound O-demethylation assessed per nmol protein";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"339.0"
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"MMV001992";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3529130";"Drug metabolism assessed as recombinant CYP2J2 (unknown origin)-mediated 3-hydroxyamiodarone formation at 1 uM after 5 to 45 mins by LC-MS/MS analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";""
"CHEMBL861";"MEPHENYTOIN";"4.0";"218.26";"0";"1.47";"Mephenytoin";"CCC1(c2ccccc2)NC(=O)N(C)C1=O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL30008";"FLUNARIZINE";"4.0";"404.50";"1";"5.39";"Flunarizine";"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1";"IC50";"'='";"760.0";"nM";"6.12";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3531439";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation after 30 mins by LC-MS/MS method in presence of 1 mM NADPH";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.76"
"CHEMBL30008";"FLUNARIZINE";"4.0";"404.50";"1";"5.39";"Flunarizine";"Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1";"IC50";"'='";"950.0";"nM";"6.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3531438";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation reduction in astemizole O-demethylation after 30 mins by LC-MS/MS method in absence of 1 mM NADPH";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"0.95"
"CHEMBL631";"PROPAFENONE";"4.0";"341.45";"0";"3.24";"Propafenone";"CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL1434";"MINOCYCLINE";"4.0";"457.48";"0";"0.19";"Minocycline";"CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL35";"FUROSEMIDE";"4.0";"330.75";"0";"1.89";"Furosemide";"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL277474";"ANTIPYRINE";"4.0";"188.23";"0";"1.48";"Antipyrin";"Cc1cc(=O)n(-c2ccccc2)n1C";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"amiodarone";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"Activity";"'='";"39.0";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"39.0"
"CHEMBL42";"CLOZAPINE";"4.0";"326.83";"0";"3.72";"CLZ";"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1";"Activity";"'='";"25.6";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530851";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated astemizole O-demethylation assessed as remaining activity at 30 uM after 5 mins by LC-MS/MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"25.6"
"CHEMBL3526949";"";"None";"661.32";"2";"5.91";"3-Hyroxyamiodarone";"CCN(CC)CCOc1c(I)cc(C(=O)c2c(CCC(C)O)oc3ccccc23)cc1I";"Drug metabolism";"";"";"";"";"";"metabolite_detected";"";"";"";"";"";"0";"CHEMBL3529129";"Drug metabolism assessed as recombinant CYP2J2 (unknown origin)-mediated compound formation treated with amiodarone at 1 uM after 5 to 45 mins by LC-MS/MS analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";""
"CHEMBL17157";"TERFENADINE";"4.0";"471.69";"1";"6.45";"Terfenadine";"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"IC50";"'='";"1130.0";"nM";"5.95";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3529113";"Inhibition of CYP2J2-mediated astemizole O-demethylation in human liver microsomes after 8 mins by LC-MS/MS analysis";"A";"BAO_0000019";"assay format";"Homo sapiens";"CHEMBL3559723";"Liver";"None";"Microsomes";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"1.13"
"CHEMBL1085745";"";"None";"365.36";"0";"3.68";"39";"O=C(NCc1ccccc1OC(F)(F)F)N1CCC(c2ccncc2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2072825";"Inhibition of CYP2J2";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2069173";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";"";"";"10.0"
"CHEMBL388590";"BENZBROMARONE";"4.0";"424.09";"1";"5.46";"Benzbromarone";"CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1";"IC50";"'='";"4260.0";"nM";"5.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"4.26"
"CHEMBL17157";"TERFENADINE";"4.0";"471.69";"1";"6.45";"TERFENADINE";"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4416900";"Inhibition of recombinant human CYP2J2 expressed in baculovirus infected insect cells co-expressing NADPH-CYP reductase and cytochrome b5 assessed as reduction in CYP2J2-mediated EPA epoxidation by measuring sum of EEQ and DiHETEs level at 1 to 50 uM using EPA as substrate preincubated for 5 mins followed by NADPH addition and measured after 15 mins by LCMS/MS analysis";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414645";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";""
"CHEMBL26";"SULPIRIDE";"4.0";"341.43";"0";"0.56";"Sulpiride";"CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL16073";"PHENACETIN";"4.0";"179.22";"0";"2.04";"Phenacetin";"CCOc1ccc(NC(C)=O)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL1008";"BEPRIDIL";"4.0";"366.55";"0";"4.83";"Bepridil";"CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1";"IC50";"'='";"11500.0";"nM";"4.94";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"11.5"
"CHEMBL1423";"PIMOZIDE";"4.0";"461.56";"1";"5.86";"Pimozide";"O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1";"Activity";"'='";"27.29";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"27.29"
"CHEMBL1510";"ELETRIPTAN";"4.0";"382.53";"0";"3.82";"Eletriptan";"CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL266195";"ALPRENOLOL";"2.0";"249.35";"0";"2.15";"Alprenolol";"C=CCc1ccccc1OCC(O)CNC(C)C";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3541093";"Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526101";"1";"Scientific Literature";"Drug Metab Dispos";"2013";"None";"";"";"";"50.0"
"CHEMBL633";"AMIODARONE";"4.0";"645.32";"2";"6.94";"Amiodarone";"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4416900";"Inhibition of recombinant human CYP2J2 expressed in baculovirus infected insect cells co-expressing NADPH-CYP reductase and cytochrome b5 assessed as reduction in CYP2J2-mediated EPA epoxidation by measuring sum of EEQ and DiHETEs level at 1 to 50 uM using EPA as substrate preincubated for 5 mins followed by NADPH addition and measured after 15 mins by LCMS/MS analysis";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414645";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";""
"CHEMBL998";"LORATADINE";"4.0";"382.89";"0";"4.89";"Loratadine";"CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1";"Activity";"'='";"11.4";"%";"";"";"";"UO_0000187";"";"";"";"";"0";"CHEMBL3530850";"Inhibition of recombinant CYP2J2 (unknown origin)-mediated terfenadine hydroxylation assessed as remaining activity at 30 uM after 5 mins by LC-MS analysis relative to control";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3526133";"1";"Scientific Literature";"Drug Metab Dispos";"2012";"None";"";"";"";"11.4"
"CHEMBL74415";"CANNABINOL";"3.0";"310.44";"1";"5.73";"10b; CBN";"CCCCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2";"IC50";"'='";"19000.0";"nM";"4.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5096666";"Non competitive inhibition of CYP2J2 (unknown origin) in presence of NADPH by LC-MS/MS analysis";"A";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5096151";"1";"Scientific Literature";"J Nat Prod";"2021";"None";"";"INHIBITOR";"";"19.0"
"CHEMBL184412";"DRONEDARONE";"4.0";"556.77";"2";"7.05";"Dronedarone";"CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1";"Inhibition";"";"";"%";"";"";"Active";"UO_0000187";"";"";"";"";"0";"CHEMBL4416900";"Inhibition of recombinant human CYP2J2 expressed in baculovirus infected insect cells co-expressing NADPH-CYP reductase and cytochrome b5 assessed as reduction in CYP2J2-mediated EPA epoxidation by measuring sum of EEQ and DiHETEs level at 1 to 50 uM using EPA as substrate preincubated for 5 mins followed by NADPH addition and measured after 15 mins by LCMS/MS analysis";"A";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL3491";"Cytochrome P450 2J2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414645";"1";"Scientific Literature";"J Med Chem";"2019";"None";"";"";"";""
